Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.

about

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.A nomogram prediction for the survival of patients with triple negative breast cancer

P2860

Q47397566-A0A64B5F-6825-49DC-BE64-D4615298EA88 Q58780435-8A7B4D0E-D4D6-4240-9494-C31A902CCD26

P2860

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.

Item

http://www.wikidata.org/entity/Q41858523

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Serum CA125 is a predictive ma ...... lates with molecular subtypes.

@en

type

Item

label

Serum CA125 is a predictive ma ...... lates with molecular subtypes.

@en

prefLabel

Serum CA125 is a predictive ma ...... lates with molecular subtypes.

@en

P1476

Serum CA125 is a predictive ma ...... lates with molecular subtypes.

@en

P2093

Cheng Fang

http://www.w3.org/2001/XMLSchema#string

Xian-Tao Zeng

http://www.w3.org/2001/XMLSchema#string

Xiaoping Liu

http://www.w3.org/2001/XMLSchema#string

Yirong Li

http://www.w3.org/2001/XMLSchema#string

Yue Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes.

Breast cancer statistics and markers.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.

The place of chemotherapy in the treatment of early breast cancer

Specific carcinoembryonic antigens of the human digestive system.

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

P304

63963-63970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19246

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28969044

http://www.w3.org/2001/XMLSchema#string

P932

5609976

http://www.w3.org/2001/XMLSchema#string

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.

about

P2860

P2860

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932